相关实验视频
Updated: Jan 7, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
2.4K
甲状腺刺激性免疫球蛋白作为甲状腺眼病的可靠预测性血液检测
Shiran Madgar1,2, Guy Ben Simon1,2, Ayelet Priel1,2
1Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer, Israel.
Indian journal of ophthalmology
|December 29, 2025
概括
甲状腺刺激性免疫球蛋白 (TSI) 与更严重的甲状腺眼病 (TED) 相相关,并预测需要医疗或手术治疗. 常规的TSI测试可能对所有TED患者都有好处.
科学领域:
- 内分泌学 在内分泌学.
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
背景情况:
- 传统的甲状腺测试可能与甲状腺眼病 (TED) 严重程度无关.
- 甲状腺刺激性免疫球蛋白 (TSI) 是一种较新的标记物,在TED中证据有限.
- TSI在预测TED活动和严重性的作用需要进一步研究.
研究的目的:
- 评估 TSI 级别与 TED 活动之间的相关性.
- 确定TSI是否可以预测甲状腺眼病的严重程度.
- 评估TED患者的TSI和治疗要求之间的关联.
主要方法:
- 从2017年到2022年,对60名TED患者的病历进行了回顾性分析.
- 包括人口统计,眼科检查,临床活动分数 (CASs) 和生活质量数据.
- 在提交时分析 TSI 血液检测结果.
主要成果:
- 与眼收缩,眼内压力 (IOP) 和CAS相关的 TSI 级别.
- 较高的TSI (>500%) 与需要高剂量的类固醇,特定的类固醇方案和放射性治疗显著相关.
- 更高的TSI水平也与轨道减压和眼手术的可能性增加有关.
结论:
- TSI是TED中更严重的临床表现的重要预测因素.
- TSI 级别与医疗和外科手术干预的需要相关.
- 建议对所有被诊断为TED的患者进行常规的TSI测试.
更多相关视频
05:41Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
Published on: February 9, 2024
1.0K
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
2.9K
相关概念视频
01:20Synthesis and Regulation of Thyroid Hormones
7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
01:15Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K